A Novel TNFSF‐Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower‐Grade Glioma
Rui Tao(Capital Medical University), Jiangfei Wang(Capital Medical University), Qi Liu(First Affiliated Hospital Zhejiang University), Ruoyu Huang(Jiangsu Hengrui Medicine (China)), Pei Yang(Capital Medical University), Kuanyu Wang(Beijing Institute of Technology), Zhiyan Sun(Capital Medical University)
Cited by 3
Related Papers
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
|NeuroImage Clinical|2018|262
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature
|European Radiology|2018|122
Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
|Advanced Science|2019|106
ZIF-8-modified hydrogel sequentially delivers angiogenic and osteogenic growth factors to accelerate vascularized bone regeneration
|Journal of Controlled Release|2024|64